NBC Securities Inc. Invests $513,000 in Chemed Co. (NYSE:CHE)

NBC Securities Inc. acquired a new position in shares of Chemed Co. (NYSE:CHE - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 834 shares of the company's stock, valued at approximately $513,000.

A number of other institutional investors have also recently bought and sold shares of the business. Neuberger Berman Group LLC lifted its position in shares of Chemed by 1.2% in the fourth quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after purchasing an additional 5,809 shares in the last quarter. Geode Capital Management LLC increased its stake in Chemed by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after buying an additional 4,966 shares during the period. FMR LLC lifted its position in Chemed by 18.9% in the 4th quarter. FMR LLC now owns 283,790 shares of the company's stock worth $150,352,000 after buying an additional 45,174 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Chemed by 8.2% in the 4th quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after buying an additional 20,310 shares in the last quarter. Finally, Epoch Investment Partners Inc. boosted its stake in shares of Chemed by 5.1% during the 4th quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock valued at $133,635,000 after buying an additional 12,167 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CHE shares. Royal Bank of Canada upped their price target on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares of the company's stock, valued at $62,566,139.07. This represents a 0.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 1,500 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $577.86, for a total value of $866,790.00. Following the transaction, the executive vice president now owns 16,127 shares in the company, valued at approximately $9,319,148.22. This trade represents a 8.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,500 shares of company stock valued at $3,213,780 over the last three months. 3.29% of the stock is currently owned by insiders.

Chemed Stock Performance

Shares of NYSE CHE traded down $13.27 during trading hours on Monday, hitting $549.14. The stock had a trading volume of 142,835 shares, compared to its average volume of 103,520. The firm's 50-day moving average price is $575.83 and its two-hundred day moving average price is $566.18. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The company has a market capitalization of $8.03 billion, a P/E ratio of 27.75, a P/E/G ratio of 2.15 and a beta of 0.54.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same period in the previous year, the company earned $5.20 earnings per share. The company's revenue was up 9.8% compared to the same quarter last year. As a group, analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Thursday, May 29th. Chemed's dividend payout ratio is presently 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.